Immune-checkpoint inhibitor-induced bullous pemphigoid in patients with metastatic renal cell carcinoma: two case reports and systematic review of the literature.
Two patients with metastatic renal cell carcinoma developed bullous pemphigoid after treatment with immune-checkpoint inhibitors.
Clinical pearl
Clinicians should be vigilant for bullous pemphigoid in patients receiving immune-checkpoint inhibitors, especially after prolonged treatment, as early recognition can facilitate timely management.